✓ Translated by DotMD AI Clinical Council Source: Journal of cosmetic dermatology • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #39555738 ↗

Randomized Controlled Trial: A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation for Patients With Androgenetic Alopecia (N = 30)

Original Paper Title: “A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation for Patients With Androgenetic Alopecia”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
N = 30
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • This prospective, comparative clinical study demonstrated that the application of PRP in conjunction with pharmacological support during FUE treatment for AGA resulted in improved follicle survival rates, hair growth rates, and hair strength.
  • Study Design & Sample: Randomized Controlled Trial published in Journal of cosmetic dermatology (N = 30 human participants).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Journal of cosmetic dermatology (2025), this randomized controlled trial evaluating 30 human participants investigated: Androgenetic alopecia (AGA) is the most prevalent type of hair loss. Key clinical takeaway: This prospective, comparative clinical study demonstrated that the application of PRP in conjunction with pharmacological support during FUE treatment for AGA resulted in improved follicle survival rates, hair growth rates, and hair strength.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Journal of cosmetic dermatology, 2025-02-15; N = 30; Rigor 82/100): This prospective, comparative clinical study demonstrated that the application of PRP in conjunction with pharmacological support during FUE treatment for AGA resulted in improved follicle survival rates, hair growth rates, and hair strength.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: topical-minoxidil-finasteride → Rx: finasteride → Rx: minoxidil → Rx: stay-minoxidil-hair-regrowth-treatment-minoxidil-5 → Condition: androgenic-alopecia → Condition: onychogryphosis →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 39555738: Randomized Controlled Trial: A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation for Patients With Androgenetic Alopecia (N = 30)

3 of 3 Free Questions Remaining